Silicosis is a preventable occupational
lung disease caused by the inhalation of respirable crystalline
silica dust and can progress to
respiratory failure and death. No effective specific treatment for
silicosis is available; patients are provided supportive care, and some patients may be considered for
lung transplantation. Chronic
silicosis can develop or progress even after occupational exposure has ceased. The number of deaths from
silicosis declined from 1,065 in 1968 to 165 in 2004. Hazardous occupational exposures to
silica dust have long been known to occur in a variety of industrial operations, including mining, quarrying, sandblasting, rock drilling, road construction, pottery making, stone masonry, and tunneling operations. Recently, hazardous
silica exposures have been newly documented during hydraulic fracturing of gas and oil wells and during fabrication and installation of engineered stone countertops. To describe temporal trends in
silicosis mortality in the United States, CDC analyzed annual multiple cause-of-death data for 2001-2010 for decedents aged ≥15 years. During 2001-2010, a total of 1,437 decedents had
silicosis coded as an underlying or contributing cause of death. The annual number of
silicosis deaths declined from 164 (death rate† = 0.74 per 1 million population) in 2001 to 101 (0.39 per 1 million) in 2010 (p = 0.002). Because of new operations and tasks placing workers at risk for
silicosis, efforts to limit workplace exposure to crystalline
silica need to be maintained.